Clearstead Advisors, LLC Emergent Bio Solutions Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 185 shares of EBS stock, worth $2,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185Holding current value
$2,012% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding EBS
# of Institutions
191Shares Held
40.2MCall Options Held
391KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$41.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$39.3 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$38.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$25.9 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.14MShares$23.3 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $542M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...